Article By:
ChinaBio® Today
Sunday, January 13, 2019 1:18 PM EDT
China's life science sector started off 2019 with $425 million from ten deals involving Apollomics, Schrödinger of New York City and BrightGene Bio-Medical of Suzhou, among others.
In this article: NVS, SPRO, CBMG, BHVN, ASLN
